%0 Journal Article
%T Solar Urticaria, a Disease with Many Dark Sides: Is Omalizumab the Right Therapeutic Response? Reflections from a Clinical Case Report
%A Lia Ginaldi
%A Maria Maddalena Sirufo
%A Massimo De Martinis
%J Archive of "Open Medicine".
%D 2019
%R 10.1515/med-2019-0042
%X Solar urticaria is a rare type of photodermatosis that significantly reduces the quality of life of the subjects affected, with a risk of anaphylaxis should the entire body be exposed to the sun. Patients are forced to modify and limit their normal activities, and since the symptoms are triggered by exposure to sun, which is difficult if not impossible to avoid in everyday life, a safe and effective therapy appears to be essential
%K Allergy
%K Solar urticaria
%K Omalizumab
%K IgE
%K Translational immunology
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6572395/